WASHINGTON - Pomegranate juice could help prevent prostate cancer recurrence, finds a new study.
During the study, the researchers followed a total of 48 participants over six years. These patients were asked to drinking eight ounces of pomegranate juice daily.
The participants had a rising PSA after surgery or radiotherapy, a PSA greater than 0.2 ng/ml and less than five ng/ml and a Gleason score of seven or less.
The men who remained in the study experienced a significant increase in PSA doubling time following treatment, from a mean of 15.4 months to 60 months, researchers said.
“This study suggests that pomegranate juice may effectively slow the progression of prostate cancer after unsuccessful treatment,” said Dr Christopher Amling, an AUA spokesman.
“This finding and other ongoing research might one day reveal that pomegranate juice is an effective prostate cancer preventative agent as well.”
The study results were presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). (ANI)
Filed under Cancer, Health, News
Related?
Green tea can slow prostate cancer from progressing (Lead, superseding earlier story)June 23rd, 2009 WASHINGTON - Researchers have discovered that an active compound called Polyphenon E found in green tea can slow the progression of prostate cancer. The study examined 26 men between the ages of 41 to 72 years, diagnosed with prostate cancer.
Agent Orange exposure 'raises prostate cancer recurrence risk'April 21st, 2009 WASHINGTON - A new study has revealed that people who have been exposed to Agent Orange, a herbicide and defoliant used during the Vietnam War, are at an increased risk of aggressive recurrence of prostate cancer. Agent Orange is the code name for a herbicide and defoliant used by the U.S.
Obesity 'ups prostate cancer recurrence risk'August 14th, 2009 WASHINGTON - A new study, led by an Indian-origin scientist, has shown that obesity increases risk of prostate cancer recurrence for both blacks and whites. Study's lead author Jayakrishnan Jayachandran, M.D.
Eat greens, lower prostate cancer riskJune 4th, 2009 SYDNEY - A diet rich in fruits and vegetables but low in fat and red meat is the new mantra for preventing and treating prostate cancer. Robert Ma and K.
Green tea may slow prostrate cancer progression: studyJune 23rd, 2009 WASHINGTON - Not only is green tea the second most popular drink in the world, but it can also significantly reduce serum markers predictive of prostrate cancer progression. James A. Cardelli, director of basic and translational research at the Feist-Weiller Cancer Centre, Louisiana said: "The investigational agent used in the trial, Polyphenon E may have the potential to lower the incidence and slow the progression of prostate cancer."
The study included 26 men between the ages of 41 to 72 years, diagnosed with prostrate cancer.
Low oxygen levels in prostate tumours can help predict odds of cancer recurrenceMay 16th, 2009 WASHINGTON - Low-oxygen regions in prostate tumours can be used to predict the recurrence of cancer in a patient, say scientists. Researchers at the Fox Chase Cancer Center came to this conclusion after analysing the observations made during a long-term study, whose results will be presented at the 2009 American Society of Clinical Oncology annual meeting in Orlando, Florida.
Combo therapy of vitamin E, selenium, soy doesn't prevent prostate cancerApril 27th, 2009 WASHINGTON - A new study, conducted by Canadian researchers, has found that the combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer. For the study, researchers divided 303 men, with an average age of 62, into two randomized groups.
Biomarkers Could Improve Predictive Accuracy of Prostrate Cancer by 15%July 14th, 2008 According to the preliminary work appearing in the issue of 15th June 2008 in Clinical Cancer Research, biomarkers can increase the accuracy of srceening methods of prostate cancer upto 15%. The researchers suggest that biomarkers such as-
* transforming growth factor-β1
* interleukin-6
* interleukin-6 soluble receptor
* vascular endothelial growth factor
* vascular cell adhesion molecule-1
* endoglin, and
* urokinase plasminogen activator.
